Ivermectin, Heparin, and COVID-19: An Interview with Dr. David Scheim

195Likes

5,931Views

2020Jul 10

Illuminating Health interviews Dr. David Scheim of the US Public Health Service about his recent publication (https://papers.ssrn.com/sol3/papers.c... ) detailing results using Ivermectin to treat COVID-19 in Florida, how treatment might be improved further, and the critical importance of blood "clumps and catches" in COVID pathogenesis. (Note that ivermectin is a drug which must be prescribed by a doctor). Please also view the clinical trial by Dr. Rajter et al. that Dr. Scheim references: https://www.medrxiv.org/content/medrx.... Dr. Scheim also discusses why heparin can be an effective treatment for COVID and why those with Type A blood are more susceptible to severe disease. For more information please visit us at www.IlluminatingHealthUSA.com . Ivermectin may be contraindicated in some medical conditions and for pregnant women and children. New: A colleague has just posted this website detailing COVID-19 treatments that doctors have found to be successful: https://healthyimmunitynow.org/ Another new link, testimony to congress about Ivermectin by Dr. Pierre Kory: https://www.hsgac.senate.gov/imo/medi... And an excellent page summarizing now available clinical research results: https://ivmmeta.com/ Update posted 8/16/2022 by Illuminating Health: It's important to note that the work we have referenced above on ivermectin was done before the Omicron wave. Dominant COVID variants are currently changing faster than clinical trials can be completed so existing data may not be relevant to the current strain. #ivermectin